Antineoplastic Drugs Flashcards

1
Q

What are the hallmarks of cancer?

A

1) Enhanced growth signals
2) Insensitivity to antigrowth signals
3) Tissue invasion and metastasis
4) Limitless replicative potential
5) Chronic inflammation
6) Sustained angiogenesis
7) Evading apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is primary resistance to chemotherapy?

A

When cancer does not respond to standard chemo from the FIRST exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is acquired resistance to chemotherapy?

A

When tumor initially responds and then becomes resistant?

Causes:
- Mutation develops pathways independent of those blocked by chemotherapy
- Cells develop mechanisms that inactivate the chemotherapeutic agent
- Cells learn to repair DNA and other protein damages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the disadvantages of combination therapy?

A
  • Multiple toxicities
  • Holding doses due to toxicity will reduce effectiveness
  • Complicated to administer
  • Expensive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the basic concepts of cancer and chemotherapy?

A

1) Cells within the tumor consists of 3 subpopulations
- Non-dividing terminally differentiated cells
- Continually proliferating cells
- Resting cells

2) Tumor growth depends on:
- Tumor doubling time
- Rate of cell loss
~ Due to immune system, tumor shedding, apoptosis and necrosis
- Growth fraction
~ Actively growing fraction of tumor

3) Tumor becomes detectable when there is at least 10^9 cells

4) Skipper-Schabel model of tumor growth
- 1 leukemic cell can be lethal to the host
- % of cells killed at any given dose is constant
~ Phenomenon of constant fractional drug kill regardless of population size
~ Multiple rounds needed to fully kill all
- % of cells killed is directly proportional to the dose level

5) Gompertzian model of tumor growth
- Growth rate of tumor cells decreases with time
- Response to chemo is during rapid growth phase

6) Goldie-Coldman hypothesis
- A fraction of tumor cells will develop resistance after treatment
- Clone will continue to grow even if px responds
- Alternating combis of chemo agents early on prevents development of treatment resistant clones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the side effects of therapy?

A
  • Affects cells with high growth fraction
    ~ Even normal cells
    ~ eg Bone marrow, hair follicles, GI mucosa, skin
  • Decreased WBC, RBC, PLT (myelosuppression)
  • Alopecia
  • Mucositis
    ~ Inflammation and ulceration of mucous membranes lining the digestive tract
  • N/V
    ~ Due to stimulation of the vomiting centre in the CNS and nerves in the GI tract
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the stages of the cell cycle?

A

1) Mitotic phase
- PMAT

2) G1 phase
- Duplicates organelles

3) S phase
- Replicates DNA

4) G2 phase
- Synthesized enzymes and proteins
- Replication of centrosomes completed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the cell cycle non-specific agents?

A

1) Alkylating agents
- Nitrogen mustards
~ CYCLCOPHOSPHAMIDE
- Ethylenimines
~ THIOTEPA
- Alkyl sulfonates
~ BUSULFAN
- Nitrosureas
~ CARMUSTINE

2) Antibiotics
- Anthracyclines
~ DOXORUBICIN
~ DAUNORUBICIN
- DACTINOMYCIN/actinomycin D

3) Cisplatin

4) Nitrosureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the cell cycle-specific agents?

A

1) Antimetabolites
- Folic acid analogs
~ METHOTREXATE
- Pyrimidine analogs
~ FLUOROURACIL
- Purine analogs
~ Mercaptoguanine

2) Plant alkaloids
- Vinca alkaloids
~ VINBLASTINE
- Podophyllotoxins
~ ELOPOSIDE
- Taxanes
~ PACLITAXEL
- Camptothecins
~ Topotecan

3) Bleomycin

4) Podophyllin alkaloids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA of alkylating agents (non cell cycle-specific)?

A
  • Binds to DNA to break it
  • Miscoding through abnormal base-pairing
    ~ Pairs guanine with thymine instead of cytosine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the major toxicities of alkylating agents (non cell cycle-specific)?

A
  • Myelosuppression
  • Alopecia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the MOA of nitrosoureas?

A
  • Alkylation of DNA & carbamylation of lysine residues on proteins
  • Can cross the blood brain barrier due to high lipid solubility
    ~ Useful in treating malignancies of the CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the MOA of anthracycline Abx (non cell-cycle specific)?

A

1) Prevents replication of rapidly-growing cancer cells
- by inhibiting DNA and RNA synthesis

2) Blocks DNA transcription and replication
- by inhibiting topoisomerase II enzyme
- relaxes supercoiled DNA

3) Creates free oxygen radicals that damage the DNA and cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the side effects of anthracycline Abx?

A
  • cardiotoxicity due to free radical production
  • alopecia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the MOA of Dactinomycin?

A
  • Intercalates in DNA minor grooves between adjacent GC pairs
  • Prevents elongation by RNA polymerase
  • Inhibits transcription
  • Inhibits topoisomerase II
  • Cytotoxic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is folate important in DNA/RNA synthesis?

A
  • Provides single carbon group for precursors for synthesis
  • To function as a cofactor, folate must be reduced by DHFR to THF
17
Q

What is the MOA of methotrexate/MTX (folic acid analogue, cell-cycle specific)?

A
  • Competitively inhibits dihydrofolate reductase (DHFR)
    ~ Enzyme which catalyses the formation of tetrahydrofolate (THF) from dihydrofolate (DHF)
    ~ tf no THF formed -> intracellular folate deficiency and accumulation of toxic DHF
  • Reactions for purine synthesis cease
    ~ Interrupts DNA and RNA synthesis
  • Often used for breast cancer etc
18
Q

What is MTX toxicity?

A

1) Bone marrow suppression
- Rescue with leucovorin / folinic acid

2) Nephrotoxic
- Give sodium bicarbonate to alkalinize the urine

19
Q

What is the MOA of 5-Fluorouracil (pyrimidine antagonists, cell cycle-specific)?

A
  • Inhibits thymidylate synthase
    ~ Depletion of thymidylate
    ~ Inhibits DNA synthesis
    ~ Fraudulent RNA formation causes cytotoxicity
20
Q

What are the major toxicities of 5-florouracil?

A
  • Myelosuppression
  • Mucositis
  • Dermatitis
  • Diarrhea
  • Cardiac toxicity
21
Q

What is Gemcitabine (antimetabolite, cell cycle specific) used for?

A
  • Inhibits DNA replication and repair
    ~ Competes with dCTP for incorporation into DNA strands
    ~ Characteristics of apoptosis
    ~ More difficult to remove from DNA strands so hard to repair
  • More used for pancreatic cancer
22
Q

What are the major toxicities of gemcitabine?

A
  • Neutropenia
  • N/V
  • Fever
23
Q

What is the MOA of vinca alkaloids (plant alkaloids, cell cycle specific)?

A
  • Inhibits microtubules assembly
    ~ Mitotic cell arrest in metaphase
  • VINBLASTINE
  • Usually used for lymphomas and leukemias
24
Q

What are the major toxicities of vinca alkaloids?

A
  • Alopecia
  • Hyponatremia
  • Myelosuppression
25
Q

What is the MOA of podophyllotoxins (plant alkaloids, cell cycle specific)?

A
  • Blocks cells in the late S-G2 phase of the cell cycle
    ~ Inhibition of topoisomerase
  • DNA damage
    ~ Through formation of a complex of drug, DNA and enzyme
26
Q

What are the major toxicities of podophyllotoxins?

A
  • Myelosuppression
  • Mucositis
  • GI tract toxicities
27
Q

What is the MOA of taxanes (cell cycle specific)?

A
  • Interferes with normal function of microtubule breakdown
    ~ Hyperstabilizes microtubule structure (cannot disassemble)
28
Q

What are the spindle poisons?

A
  • Vinca alkaloids (prevent assembly of spindles during mitosis)
  • Taxanes (prevent disassembly of spindles)
  • Mostly used for lung, ovarian, breast, head and neck cancers
29
Q

What are the major toxicities of taxanes?

A
  • Myelosuppression
  • Alopecia
  • Neuropathy
  • Allergies
30
Q

What are molecular targeted therapies?

A
  • Block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and progression

Advantages:
- ^ therapeutic index
- Less harmful to normal cells
- ^ drug distribution to tumors using Ab-drug conjugates (ADC)

31
Q

What are some examples of molecular targeted therapies?

A

1) Monoclonal Abx
- Cituximab (anti-EGFR monoclonal Ab)
~ Binds to extracellular domain of EGFR and blocks its downstream signalling
- Herceptin (monoclonal Ab)
~ Binds to extracellular domain of HER2 receptor
~ Ab-dependent cell-mediated cytotoxicity

2) Small molecule inhibitors
- Erlotinib/Geftinib (tyrosine kinase inhibitors)
~ Blocks EGFR signalling by competitively binding to ATP pockets
- Bortezomib
~ Usually used for multiple myeloma (Abnormal expansion of plasma cells in bone marrow)

32
Q

What is acute lymphocytic leukemia (ALL) and what are the s/s?

A
  • Cancer of the blood and bone marrow

s/s:
- Bleeding gums, nosebleeds
- Bone pain
- Lumps in swollen ymph nodes
- Fever
- Pale skin
- SOB
- Fatique
- Frequent infx

33
Q

What are the treatment phases for ALL?

A

1) Induction
- Kill most of the leukemia cells
- Restore normal blood cell production
- VINCRISTINE, DAUNORUBICIN

2) Consolidation
- Destroy any remaining leukemia, eg in brain or spinal cord
- VINCRISTINE, DAUNORUBICIN, Cyclophosphamide, Etoposide

3) Maintenance
- Prevents leukemia cells from re-growing
- Much lower doses, over a long period of time

in Targeted therapies:
- Leukemia cells have Philadelphia chromosome -> new gene BCR-ABL
~ Has a protein that allows cells to grow
- Tyrosine kinase inhibitors (TKIs) attack problem
- IMATINIB MESYLATE, PONATINIB

34
Q

What are the adverse effects of treatment for ALL?

A
  • N/V
  • Diarrhea
  • Edema
  • Swelling in legs, or around the eyes
  • Usually not as severe, and can be managed
35
Q

What is Hodgkin’s lymphoma (HL)?

A
  • Malignant cells are termed lymphocyte predominant (LP) cells
    ~ Positive fro CD20 and lack CD30
36
Q

What is the treatment for HL?

A
  • Chemo + radio
  • 2nd-line
    ~ High dose chemo + autologous stem cell transplantation (ASCT)
  • Targeted therapies
    ~ CD30 Ab-drug conjugate + PD-1 inhibitors
    ~ BRENTUXIMAB VEDOTIN + NIVOLUMAB, PEMBROLIZUMAB